Prostaglandin E2 prevents hyperosmolar-induced human mast cell activation through prostanoid receptors EP2 and EP4. 2014

Ivonne Torres-Atencio, and Erola Ainsua-Enrich, and Fernando de Mora, and César Picado, and Margarita Martín
Unidad de Farmacología, Facultad de Medicina, Universidad de Panamá, Panama, Panama Republic; Laboratori d'Immunoal·lèrgia Respiratòria Clínica i Experimental, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

BACKGROUND Mast cells play a critical role in allergic and inflammatory diseases, including exercise-induced bronchoconstriction (EIB) in asthma. The mechanism underlying EIB is probably related to increased airway fluid osmolarity that activates mast cells to the release inflammatory mediators. These mediators then act on bronchial smooth muscle to cause bronchoconstriction. In parallel, protective substances such as prostaglandin E2 (PGE2) are probably also released and could explain the refractory period observed in patients with EIB. OBJECTIVE This study aimed to evaluate the protective effect of PGE2 on osmotically activated mast cells, as a model of exercise-induced bronchoconstriction. METHODS We used LAD2, HMC-1, CD34-positive, and human lung mast cell lines. Cells underwent a mannitol challenge, and the effects of PGE2 and prostanoid receptor (EP) antagonists for EP(1-4) were assayed on the activated mast cells. Beta-hexosaminidase release, protein phosphorylation, and calcium mobilization were assessed. RESULTS Mannitol both induced mast cell degranulation and activated phosphatidyl inositide 3-kinase and mitogen-activated protein kinase (MAPK) pathways, thereby causing de novo eicosanoid and cytokine synthesis. The addition of PGE2 significantly reduced mannitol-induced degranulation through EP(2) and EP(4) receptors, as measured by beta-hexosaminidase release, and consequently calcium influx. Extracellular-signal-regulated kinase 1/2, c-Jun N-terminal kinase, and p38 phosphorylation were diminished when compared with mannitol activation alone. CONCLUSIONS Our data show a protective role for the PGE2 receptors EP(2) and EP(4) following osmotic changes, through the reduction of human mast cell activity caused by calcium influx impairment and MAP kinase inhibition.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008353 Mannitol A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity. (L)-Mannitol,Osmitrol,Osmofundin
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D009997 Osmotic Pressure The pressure required to prevent the passage of solvent through a semipermeable membrane that separates a pure solvent from a solution of the solvent and solute or that separates different concentrations of a solution. It is proportional to the osmolality of the solution. Osmotic Shock,Hypertonic Shock,Hypertonic Stress,Hypotonic Shock,Hypotonic Stress,Osmotic Stress,Hypertonic Shocks,Hypertonic Stresses,Hypotonic Shocks,Hypotonic Stresses,Osmotic Pressures,Osmotic Shocks,Osmotic Stresses,Pressure, Osmotic,Pressures, Osmotic,Shock, Hypertonic,Shock, Hypotonic,Shock, Osmotic,Shocks, Hypertonic,Shocks, Hypotonic,Shocks, Osmotic,Stress, Hypertonic,Stress, Hypotonic,Stress, Osmotic,Stresses, Hypertonic,Stresses, Hypotonic,Stresses, Osmotic
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004234 Diuretics, Osmotic Compounds that increase urine volume by increasing the amount of osmotically active solute in the urine. Osmotic diuretics also increase the osmolarity of plasma. Osmotic Diuretic,Osmotic Diuretics,Diuretic, Osmotic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001250 Asthma, Exercise-Induced Asthma attacks following a period of exercise. Usually the induced attack is short-lived and regresses spontaneously. The magnitude of postexertional airway obstruction is strongly influenced by the environment in which exercise is performed (i.e. inhalation of cold air during physical exertion markedly augments the severity of the airway obstruction; conversely, warm humid air blunts or abolishes it). Bronchospasm, Exercise-Induced,Exercise-Induced Asthma,Exercise-Induced Bronchospasm,Asthma, Exercise Induced,Bronchospasm, Exercise Induced,Exercise Induced Asthma,Exercise Induced Bronchospasm,Exercise-Induced Asthmas,Exercise-Induced Bronchospasms
D015232 Dinoprostone The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. PGE2,PGE2alpha,Prostaglandin E2,Prostaglandin E2alpha,PGE2 alpha,Prepidil Gel,Prostaglandin E2 alpha,Prostenon,E2 alpha, Prostaglandin,E2, Prostaglandin,E2alpha, Prostaglandin,Gel, Prepidil,alpha, PGE2,alpha, Prostaglandin E2
D015550 Cell Degranulation The process of losing secretory granules (SECRETORY VESICLES). This occurs, for example, in mast cells, basophils, neutrophils, eosinophils, and platelets when secretory products are released from the granules by EXOCYTOSIS. Degranulation, Cell

Related Publications

Ivonne Torres-Atencio, and Erola Ainsua-Enrich, and Fernando de Mora, and César Picado, and Margarita Martín
February 2011, The Journal of pharmacology and experimental therapeutics,
Ivonne Torres-Atencio, and Erola Ainsua-Enrich, and Fernando de Mora, and César Picado, and Margarita Martín
March 2012, The Journal of pharmacology and experimental therapeutics,
Ivonne Torres-Atencio, and Erola Ainsua-Enrich, and Fernando de Mora, and César Picado, and Margarita Martín
October 2004, European journal of pharmacology,
Ivonne Torres-Atencio, and Erola Ainsua-Enrich, and Fernando de Mora, and César Picado, and Margarita Martín
July 2006, Immunology,
Ivonne Torres-Atencio, and Erola Ainsua-Enrich, and Fernando de Mora, and César Picado, and Margarita Martín
April 2006, British journal of pharmacology,
Ivonne Torres-Atencio, and Erola Ainsua-Enrich, and Fernando de Mora, and César Picado, and Margarita Martín
September 2011, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Ivonne Torres-Atencio, and Erola Ainsua-Enrich, and Fernando de Mora, and César Picado, and Margarita Martín
January 2002, The Journal of biological chemistry,
Ivonne Torres-Atencio, and Erola Ainsua-Enrich, and Fernando de Mora, and César Picado, and Margarita Martín
July 2017, Molecular medicine reports,
Ivonne Torres-Atencio, and Erola Ainsua-Enrich, and Fernando de Mora, and César Picado, and Margarita Martín
March 2016, British journal of pharmacology,
Ivonne Torres-Atencio, and Erola Ainsua-Enrich, and Fernando de Mora, and César Picado, and Margarita Martín
July 2005, Molecular pharmacology,
Copied contents to your clipboard!